DDX5 and hepatocellular carcinoma: Moreover, we demonstrate that DDX5 knockout HCC cells display sustained activation of Wnt signaling, as well as of the interconnected non-canonical NF-κB and NRF2 pathways, even in the absence of sorafenib treatment.